Tumor xenograft experiments showed that NLRP7 or USP10 knockdown inhibited the growth of HCT116 tumors in vivo, whereas overexpression of NLRP7 in USP10 knockdown cells had a synergistic effect on tumor growth (Fig. 4d). The gene discussed is NLRP7; the disease is neoplasm.